Transient Ischemic Attack (TIA)Symptoms, Doctors, Treatments, Advances & More
Learn About Transient Ischemic Attack (TIA)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Penn - Medical Group
Brett Cucchiara is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Cucchiara is rated as an Elite provider by MediFind in the treatment of Transient Ischemic Attack (TIA). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Migraine with Brainstem Aura, Thrombectomy, and Stent Placement. Dr. Cucchiara is board certified in Vascular Neurology, American Board Of Psychiatry & Neurology.
Emory Clinic At 1365 Clifton Road
Fadi Nahab is a Neurologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 23 years. Dr. Nahab is rated as an Elite provider by MediFind in the treatment of Transient Ischemic Attack (TIA). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Subarachnoid Hemorrhage, Thrombectomy, and Cerebral Artery Bypass Surgery. Dr. Nahab is board certified in American Board Of Psychiatry And Neurology, 2011.
Office
Gregg Fonarow is a Cardiologist practicing medicine in Los Angeles, California. Dr. Fonarow is rated as an Elite provider by MediFind in the treatment of Transient Ischemic Attack (TIA). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Attack, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Thrombectomy.
Summary: The project is a multicenter, open-label, randomized medical experiment, which was designed to evaluate the efficacy and safety of single-stage pulmonary vein isolation (PVI) and implantation of left atrial appendage occluder (LAAO) in comparison with either isolated LAAO implantation or chronic therapy with non-vitamin K antagonists anticoagulants (NOAC) in patients with recent-onset ischemic str...
Summary: The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.